Mural Oncology plc (MURA)
NASDAQ: MURA · Real-Time Price · USD
1.240
-0.020 (-1.59%)
At close: Apr 1, 2025, 4:00 PM
1.290
+0.050 (4.03%)
After-hours: Apr 1, 2025, 4:22 PM EDT
Mural Oncology Stock Forecast
MURA's stock price has decreased by -74.85% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 4 analysts with 12-month price forecasts for Mural Oncology stock have an average target of 13, with a low estimate of 6.00 and a high estimate of 18. The average target predicts an increase of 948.39% from the current stock price of 1.24.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Mural Oncology stock from 5 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 4 | 4 | 3 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 5 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $18 → $6 | Strong Buy | Maintains | $18 → $6 | +383.87% | Mar 26, 2025 |
| Jones Trading | Jones Trading | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Mar 25, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $18 | Strong Buy | Reiterates | $18 | +1,351.61% | Mar 12, 2025 |
| Jones Trading | Jones Trading | Strong Buy Initiates $16 | Strong Buy | Initiates | $16 | +1,190.32% | Jan 27, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $18 | Strong Buy | Reiterates | $18 | +1,351.61% | Nov 14, 2024 |
Financial Forecast
Revenue This Year
150.93M
from 84.02M
Increased by 79.64%
Revenue Next Year
n/a
from 150.93M
EPS This Year
-5.07
from -7.58
EPS Next Year
-2.88
from -5.07
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | n/a | 27.4M | 22.4M | ||
| Avg | n/a | 10.4M | 21.7M | ||
| Low | n/a | 3.4M | 20.9M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | 115.3% | ||
| Avg | - | - | 109.2% | ||
| Low | - | - | 101.0% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -4.41 | -2.22 | -1.19 | ||
| Avg | -5.07 | -2.88 | -2.04 | ||
| Low | -5.54 | -3.73 | -3.34 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.